220 related articles for article (PubMed ID: 29666203)
1. Efficacy and safety of pulmonary application of corticosteroids in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis.
Delara M; Chauhan BF; Le ML; Abou-Setta AM; Zarychanski R; 'tJong GW
Arch Dis Child Fetal Neonatal Ed; 2019 Mar; 104(2):F137-F144. PubMed ID: 29666203
[TBL] [Abstract][Full Text] [Related]
2. Early Intratracheal Administration of Corticosteroid and Pulmonary Surfactant for Preventing Bronchopulmonary Dysplasia in Preterm Infants with Neonatal Respiratory Distress Syndrome: A Meta-analysis.
Zhong YY; Li JC; Liu YL; Zhao XB; Male M; Song DK; Bai Y
Curr Med Sci; 2019 Jun; 39(3):493-499. PubMed ID: 31209823
[TBL] [Abstract][Full Text] [Related]
3. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2004; (3):CD003063. PubMed ID: 15266470
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of different inhaled corticosteroids for bronchopulmonary dysplasia prevention in preterm infants: A systematic review and meta-analysis.
Zhang M; Zhang W; Liao H
Respir Med Res; 2024 Jun; 85():101096. PubMed ID: 38744231
[TBL] [Abstract][Full Text] [Related]
5. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
6. Inhaled Corticosteroids for Bronchopulmonary Dysplasia: A Meta-analysis.
Shinwell ES; Portnov I; Meerpohl JJ; Karen T; Bassler D
Pediatrics; 2016 Dec; 138(6):. PubMed ID: 27940717
[TBL] [Abstract][Full Text] [Related]
7. Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday H; Shah VS
Cochrane Database Syst Rev; 2003; (1):CD002058. PubMed ID: 12535425
[TBL] [Abstract][Full Text] [Related]
8. Early surfactant administration with brief ventilation vs selective surfactant and continued mechanical ventilation for preterm infants with or at risk for RDS.
Stevens TP; Blennow M; Soll RF
Cochrane Database Syst Rev; 2002; (2):CD003063. PubMed ID: 12076469
[TBL] [Abstract][Full Text] [Related]
9. Inhaled nitric oxide in preterm infants: a systematic review.
Donohue PK; Gilmore MM; Cristofalo E; Wilson RF; Weiner JZ; Lau BD; Robinson KA; Allen MC
Pediatrics; 2011 Feb; 127(2):e414-22. PubMed ID: 21220391
[TBL] [Abstract][Full Text] [Related]
10. Airway administration of corticosteroids for prevention of bronchopulmonary dysplasia in premature infants: a meta-analysis with trial sequential analysis.
Zhang ZQ; Zhong Y; Huang XM; Du LZ
BMC Pulm Med; 2017 Dec; 17(1):207. PubMed ID: 29246209
[TBL] [Abstract][Full Text] [Related]
11. Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants.
Shah SS; Ohlsson A; Halliday H; Shah VS
Cochrane Database Syst Rev; 2003; (2):CD002057. PubMed ID: 12804423
[TBL] [Abstract][Full Text] [Related]
12. Antenatal corticosteroids in preterm small-for-gestational age infants: a systematic review and meta-analysis.
Blankenship SA; Brown KE; Simon LE; Stout MJ; Tuuli MG
Am J Obstet Gynecol MFM; 2020 Nov; 2(4):100215. PubMed ID: 33345924
[TBL] [Abstract][Full Text] [Related]
13. Animal derived surfactant extract for treatment of respiratory distress syndrome.
Seger N; Soll R
Cochrane Database Syst Rev; 2009 Apr; (2):CD007836. PubMed ID: 19370695
[TBL] [Abstract][Full Text] [Related]
14. Paracetamol (acetaminophen) for patent ductus arteriosus in preterm or low-birth-weight infants.
Ohlsson A; Shah PS
Cochrane Database Syst Rev; 2015 Mar; (3):CD010061. PubMed ID: 25758061
[TBL] [Abstract][Full Text] [Related]
15. Association of Chorioamnionitis With Bronchopulmonary Dysplasia Among Preterm Infants: A Systematic Review, Meta-analysis, and Metaregression.
Villamor-Martinez E; Álvarez-Fuente M; Ghazi AMT; Degraeuwe P; Zimmermann LJI; Kramer BW; Villamor E
JAMA Netw Open; 2019 Nov; 2(11):e1914611. PubMed ID: 31693123
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of systemic hydrocortisone for the prevention of bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis.
Morris IP; Goel N; Chakraborty M
Eur J Pediatr; 2019 Aug; 178(8):1171-1184. PubMed ID: 31144162
[TBL] [Abstract][Full Text] [Related]
17. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
Shah SS; Ohlsson A
Cochrane Database Syst Rev; 2003; (2):CD004213. PubMed ID: 12804505
[TBL] [Abstract][Full Text] [Related]
18. Multiple versus single doses of exogenous surfactant for the prevention or treatment of neonatal respiratory distress syndrome.
Soll R; Ozek E
Cochrane Database Syst Rev; 2009 Jan; (1):CD000141. PubMed ID: 19160177
[TBL] [Abstract][Full Text] [Related]
19. Early versus delayed selective surfactant treatment for neonatal respiratory distress syndrome.
Yost CC; Soll RF
Cochrane Database Syst Rev; 2000; (2):CD001456. PubMed ID: 10796266
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of the intratracheal administration of corticosteroids for the prevention of bronchopulmonary dysplasia: A meta-analysis.
Zheng Y; Xiu W; Lin Y; Ren Y; Zhang B; Yang C
Pediatr Pulmonol; 2019 Nov; 54(11):1722-1734. PubMed ID: 31397120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
